Literature DB >> 23449749

Hematological malignancies in Al-amal oncology unit, aden.

Waiel Al-Kahiry1.   

Abstract

The hematological malignancies (HM) are group of neoplasms that arise through malignant transformation of bone marrow derived cells. The great diversity seen in this group of disorders is a reflection of the complexity of normal hematopoiesis and the immune system. In the current study, the author retrospectively studied HM patients from 2008 to 2010, and compared with prevalence of solid tumor, and found HM represented one-fifth of all malignancies managed in the Oncology Unit, and lymphomas were the commonest HM.

Entities:  

Keywords:  Aden; Hematological; Malignancies; NHL

Year:  2011        PMID： 23449749      PMCID： PMC3311976          DOI： 10.1007/s12288-011-0101-3

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  10 in total

1.  Newly diagnosed cases of hematologic malignancies in Sardinia in the early 2000: an estimation of their number, age and geographic distribution on the basis of a previous epidemiologic survey.

Authors:  Giorgio Broccia; Attilio Gabbas; Maurizio Longinotti
Journal:  Haematologica       Date:  2005-03       Impact factor: 9.941

Review 2.  Epidemiology of hematological malignancies.

Authors:  D Rodriguez-Abreu; A Bordoni; E Zucca
Journal:  Ann Oncol       Date:  2007-01       Impact factor: 32.976

Review 3.  Plasma cell dyscrasias: current status.

Authors:  R A Kyle; P A Greipp
Journal:  Crit Rev Oncol Hematol       Date:  1988       Impact factor: 6.312

4.  Hematological malignancies in the island of Sardinia, 1974-1993: age and sex distributions and temporal changes in incidence.

Authors:  G Broccia; Wilma Deplano; P Dessalvi; Barbara Giannico; G Luxi; E Chessa; Antonietta Murru
Journal:  Hematol Oncol       Date:  2004-09       Impact factor: 5.271

5.  Outcome of patients with hematological malignancies admitted to the intensive care unit with life-threatening complications.

Authors:  Ahmed S Bahammam; Sayed J Basha; Mohammed I Masood; Shafi A Shaik
Journal:  Saudi Med J       Date:  2005-02       Impact factor: 1.484

6.  Incidence of hematological malignancies in Martinique, French West Indies, overrepresentation of multiple myeloma and adult T cell leukemia/lymphoma.

Authors:  C Besson; C Gonin; A Brebion; C Delaunay; G Panelatti; Y Plumelle
Journal:  Leukemia       Date:  2001-05       Impact factor: 11.528

7.  Five years cancer incidence in Aden Cancer Registry, Yemen (2002-2006).

Authors:  Huda Omer Ba Saleem; Amin Ahmed Bawazir; Malcolm Moore; Khaled Abdulla Al-Sakkaf
Journal:  Asian Pac J Cancer Prev       Date:  2010

8.  Age and sex distributions of hematological malignancies in the U.K.

Authors:  R J McNally; D Rowland; E Roman; R A Cartwright
Journal:  Hematol Oncol       Date:  1997-11       Impact factor: 5.271

9.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702

10.  Battling the hematological malignancies: the 200 years' war.

Authors:  Marshall A Lichtman
Journal:  Oncologist       Date:  2008-02
  10 in total
  2 in total

1.  Outcome of adult acute lymphoblastic leukemia in South East of iran (zahedan).

Authors:  Mohammad Ali Mashhadi; Mohhamad Mahdi Koushyar; Mehdi Mohammadi
Journal:  Iran J Cancer Prev       Date:  2012

2.  Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years.

Authors:  Mounia Elidrissi Errahhali; Manal Elidrissi Errahhali; Redouane Boulouiz; Meryem Ouarzane; Mohammed Bellaoui
Journal:  BMC Cancer       Date:  2016-02-25       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.